Effect of antiglaucoma medications on choroidal thickness

Evaluation the effect of antiglaucoma medications on choroidal layer thickness in healthy young volunteers

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180203038597N1

Enrollment

Registered

2018-03-10

Start date

2016-11-05

Completion date

Unknown

Last updated

2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

choroidal thickness.

Interventions

Intervention 1: Intervention group: right eye of volunteers randomly assigned to one of antiglaucoma drugs. Intervention 2: Control group: artificial tear instilled in the left eye of participants.

Eligibility

Sex/Gender

All

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Healthy young patients

Exclusion criteria

Exclusion criteria: History of ocular disease Allergy to antiglaucoma medications Pregnancy and breastfeeding

Design outcomes

Primary

Measure	Time frame
Choroidal thickness. Timepoint: Before medication instillation and at the peak of effect. Method of measurement: Heidelburg EDI OCT.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNasser Shoeibi

Mashhad University of Medical Sciences

shoeibin@mums.ac.ir+98 51 3728 1401

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026